Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1714098

	registered interest
	date	26/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Warrington South
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many additional NHS dental appointments have been made available for patients as a result of the Dental Recovery Plan in Warrington South constituency.
	tabling member constituency	Warrington South
	tabling member printed	Andy Carter
	uin	23962
	answer	answer is ministerial correction date of answer 08/05/2024 answer text <p>Our Dentistry Recovery Plan, backed by £200 million, will make dental services faster, simpler, and fairer for National Health Service dental patients. It will fund approximately 2.5 million additional appointments, or more than 1.5 million additional courses of dental treatment. A New Patient Premium is supporting dentists to take on new patients and since the end of January, nearly 500 more practices have said they are open to new patients.</p><p>We are committed to evaluating the impacts of the measures included in our plan, and we will publish monthly data on progress once available. Dentists have two months from the date of completion of a course of NHS treatment to submit an FP17 claim for payment.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom question first answered 08/05/2024 14:37:39 answering member 4117 label Biography information for Andrea Leadsom previous answer version 31895 answering member constituency South Northamptonshire answering member printed Andrea Leadsom answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4791 label Biography information for Andy Carter

1714123

	registered interest
	date	26/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Shingles: Warrington
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to help increase uptake of the shingles vaccine by people aged over 65 in Warrington.
	tabling member constituency	Warrington South
	tabling member printed	Andy Carter
	uin	23963
	answer	answer is ministerial correction date of answer 01/05/2024 answer text <p>The Joint Committee on Vaccination and Immunisation has recommended that those who are eligible for the shingles vaccine should change, to allow individuals to be protected at an earlier age, particularly those that have a weakened immune system. Based on the evidence, they recognised that there may be more clinical benefit from starting shingles vaccinations at a lower age, with modelling indicating that a greater number of cases of shingles would be prevented with vaccination at 60 years old for immunocompetent individuals, and 50 years old for immunosuppressed individuals. The committee advised that the programme should be implemented in stages, starting with those that are over 50 years old with a weakened immune system and those turning 65 and 70 years old, then eventually moving down to those turning 60 years old. This is a similar pattern to the roll out of the shingles vaccine from 2013. This is why the vaccine offer has been expanded to all those turning 65 and 70 years old and all those over 50 years old with a weakened immune system, from 1 September 2023. The programme began on 1 September 2023 and will run until 31 August 2028, offering the vaccine to people as they turn 65 and 70 years old, until the offer has been made to all those aged 65 to 70 years old. It will then expand to offering the vaccine to all those that are turning 60 and 65 years old, from 1 September 2028.</p><p>The shingles vaccine is available through general practice (GP) surgeries in primary care, and GPs are required to identify and put in place a call or recall arrangement to offer the shingles vaccination to eligible patients. All eligible patients are contacted by their GP surgery to invite them for vaccination. The GP will then follow up with letters or with calls and text messages, to encourage eligible people that have not come forward to take up the offer.</p><p> </p><p>There is a wide range of public facing information to help increase uptake of the shingles vaccine, and to publicise the programme in GP surgeries and online, including display bunting, leaflets, and posters. GPs are also adding messages regarding shingles to their practice websites, prescription counterfoils, and social media banners. Public facing information regarding the shingles vaccination programme includes translations into over 20 different languages including braille, audio, large print, and British Sign Language. Information for healthcare professionals, including GP toolkits for improving uptake of shingles vaccination, has also been produced and published by local immunisation commissioning teams.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 01/05/2024 12:52:34 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4791 label Biography information for Andy Carter

1662750

	registered interest
	date	13/10/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Endoscopy: North West
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce endoscopy waiting lists in (a) Cheshire and Merseyside Integrated Care System and (b) Warrington.
	tabling member constituency	Warrington South
	tabling member printed	Andy Carter
	uin	200604
	answer	answer is ministerial correction date of answer 19/10/2023 answer text <p>In July 2023, Cheshire and Merseyside Integrated Care System (ICS) delivered 1,997 more gastroscopy procedures in July 2023 than in July 2018. Alongside this increase of almost 2,000 procedures, 70% of patients who require a gastroscopy are now seen within six weeks.</p><p>Cheshire and Merseyside ICS has also secured funding to support the delivery of more than 1,000 additional endoscopy procedures across Cheshire and Merseyside by the end of December 2023. Cheshire and Merseyside’s Diagnostic Programme is also progressing a number of workforce initiatives including a collaborative staff bank for the endoscopy workforce and an endoscopy academy to provide training and upskilling for the endoscopy workforce.</p><p>Cutting National Health Service waiting lists, including for endoscopy services, is one of this Government’s top priorities. This is a shared ambition amongst ICSs, including the Cheshire and Merseyside ICS.</p><p>£2.3 billion was awarded at the 2021 Spending Review to transform diagnostic services over the next three years to increase diagnostic capacity, including for endoscopy services. This funding will also increase the number of community diagnostic centres up to 160 by March 2025, including a number delivering endoscopy services.</p> answering member constituency Colchester answering member printed Will Quince question first answered 19/10/2023 11:09:42 answering member 4423 label Biography information for Will Quince
	tabling member	4791 label Biography information for Andy Carter

1581812

	registered interest
	date	30/01/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: Warrington
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what support his Department has provided to increase the availability of NHS dental appointments in Warrington in the last 12 months.
	tabling member constituency	Warrington South
	tabling member printed	Andy Carter
	uin	135411
	answer	answer is ministerial correction date of answer 06/02/2023 answer text <p>In September 2022, we announced ‘Our plan for patients’, which outlines how we will meet oral health needs and increase access to dental care, including in Warrington. These will increase access to NHS dentistry whilst making the NHS dental contract more attractive to dental practices.</p><p>We have taken action to implement these changes, including through regulations that came into effect on 25th November 2022. The changes include a contractual requirement for NHS dentists to keep their NHS.UK profiles up to date, adherence to risk-based recall intervals, and enabling dentists to make better use of their team resources. The contractual changes of 28th December 2022 also provide for the commissioning of 110% of contracted Units of Dental Activities so that practices can deliver more NHS care, particularly in those areas where NHS dentistry is less prevalent.</p><p>NHS England is holding further discussions with the British Dental Association and other stakeholders for additional reforms of the NHS Dental System planned to take place in 2023</p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 06/02/2023 14:25:43 answering member 4679 label Biography information for Neil O'Brien
	tabling member	4791 label Biography information for Andy Carter

1545277

	registered interest
	date	24/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Illness: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what proportion of mental health spending on drugs trials takes place in the North West of England.
	tabling member constituency	Warrington South
	tabling member printed	Andy Carter
	uin	95952
	answer	answer is ministerial correction date of answer 30/11/2022 answer text <p>The Department funds research through the National Institute for Health and Care Research (NIHR). Since 2018, the NIHR has invested approximately £41 million through research programmes on pharmaceutical trials in mental health. Of this, £836,772 has been awarded to organisations in the North West of England. The NIHR welcomes funding applications for research into any aspect of human health, including mental health. Applications are subject to peer review and judged in open competition, with awards made on the basis of the importance of the topic to patients and health and care services, value for money and scientific quality. It is not usual practice to ring-fence funds for particular topics or conditions.</p> answering member constituency Colchester answering member printed Will Quince question first answered 30/11/2022 17:59:42 answering member 4423 label Biography information for Will Quince
	tabling member	4791 label Biography information for Andy Carter

1540515

	registered interest
	date	08/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Olaparib
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department is taking steps to make Olaparib available on the NHS for people with prostate cancer.
	tabling member constituency	Warrington South
	tabling member printed	Andy Carter
	uin	82462
	answer	answer is ministerial correction date of answer 15/11/2022 answer text <p>In October 2022, the National Institute for Health and Care Excellence (NICE) published guidance which does not recommend olaparib for the treatment of prostate cancer. ‘Olaparib for previously treated BRCA mutation-positive hormone-relapsed metastatic prostate cancer’ is available at the following link:</p><p><a href="https://www.nice.org.uk/guidance/ta831" target="_blank">https://www.nice.org.uk/guidance/ta831</a></p><p>NICE continues to survey new evidence which may affect its published guidance and would consult on proposed changes with a wide range of stakeholders if significant new evidence were to emerge.</p> answering member constituency Colchester answering member printed Will Quince question first answered 15/11/2022 14:36:13 answering member 4423 label Biography information for Will Quince
	tabling member	4791 label Biography information for Andy Carter

1490521

	registered interest
	date	19/07/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Bowel Cancer: Bevacizumab
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department plans to take steps to make Avastin available on the NHS for people with stage 3 or 4 bowel cancer.
	tabling member constituency	Warrington South
	tabling member printed	Andy Carter
	uin	40009
	answer	answer is ministerial correction date of answer 26/07/2022 answer text <p>Bevacizumab (Avastin) is not routinely funded on the National Health Service in England. In 2012, the National Institute for Health and Care Excellence (NICE) considered the clinical and cost-effectiveness of bevacizumab for the treatment of metastatic colorectal cancer in adults. However, it was unable to recommend the drug as an effective use of resources. NICE monitors new evidence which may affect its guidance and would consult on proposed changes with stakeholders if any such evidence emerges.</p><p>Where a treatment is not routinely commissioned by the NHS, a patient’s clinician may submit an individual funding request if they consider it is in the patient’s best interests.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 26/07/2022 16:26:12 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4791 label Biography information for Andy Carter